Hematology
Conference Coverage
Durable responses with anti-BCMA CAR T-cell for multiple myeloma
Seventy-two percent of patients with relapsed/refractory multiple myeloma had ongoing responses at the time of data cutoff in the CARTITUDE-1...
Conference Coverage
Allogeneic transplant leads to durable remissions in T-cell lymphomas
Retrospective study demonstrates overall survival over 50% at 5 years, though transplant-related mortality and graft-versus-host disease need to...
Conference Coverage
ZUMA-5: Axi-cel yields high response rate in indolent NHL
The CAR T-cell therapy had a favorable safety profile and a median duration of response that had not been reached at a median of 17.5 months...
Conference Coverage
COVID-19–related outcomes poor for patients with hematologic disease in ASH registry
Conference Coverage
VTE prophylaxis is feasible, effective in some high-risk cancer patients
Conference Coverage
Practice-changing data at this year’s ASH meeting
News
CMS launches hospital-at-home program to free up hospital capacity
The agency will be giving more flexibility to ambulatory surgery centers (ASCs) to provide hospital-level care.
Article
Using telehealth to deliver palliative care to cancer patients
Dr. Alan Lyss discusses the use of telehealth for palliative cancer care, including results from the REACH PC trial.
Conference Coverage
Novel agents hold promise for frontline AML treatment
News
COVID-19: Thromboembolic events high despite prophylaxis
“Standard prophylaxis as recommended in the guidelines is a low dose of low-molecular-weight...